Exact Mass: 457.1876

Exact Mass Matches: 457.1876

Found 127 metabolites which its exact mass value is equals to given mass value 457.1876, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Minocycline

(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

C23H27N3O7 (457.1849)

Minocycline is only found in individuals that have used or taken this drug. It is a tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections. [PubChem]Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3205 KEIO_ID M159; [MS3] KO009052 KEIO_ID M159; [MS2] KO009051 KEIO_ID M159

AZIMILIDE

C23H28ClN5O3 (457.1881)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

OA-6129 A

Antibiotic OA 6129A

C20H31N3O7S (457.1883)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Azimilide

2,4-Imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-, dihydrochloride

C23H28ClN5O3 (457.1881)

(4S,4As,5aR,12aS)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

C23H27N3O7 (457.1849)

Etrasimod

2-(7-{[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy}-1H,2H,3H,4H-cyclopenta[b]indol-3-yl)acetic acid

C26H26F3NO3 (457.1865)

Triazoledione

1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-4-(2-phenoxyethyl)-1,2,4-triazolidine-3,5-dione

C23H28ClN5O3 (457.1881)

1-[[5-(4-Chlorophenyl)furan-2-yl]methylideneamino]-4-hydroxy-3-[4-(4-methylpiperazin-1-yl)butyl]imidazol-2-one

1-({[5-(4-chlorophenyl)furan-2-yl]methylidene}amino)-4-hydroxy-3-[4-(4-methylpiperazin-1-yl)butyl]-2,3-dihydro-1H-imidazol-2-one

C23H28ClN5O3 (457.1881)

(2,3-dihydro-1-oxo-1H-pyrrolo[1,2-a]pyrrol-7-yl)methyl (2S,3S)-3-[(beta-D-glucopyranosyl)oxy]-2-hydroxy-2-(1-methylethyl)butanoate

(2,3-dihydro-1-oxo-1H-pyrrolo[1,2-a]pyrrol-7-yl)methyl (2S*,3S*)-3-[(beta-D-glucopyranosyl)oxy]-2-hydroxy-2-(1-methylethyl)butanoate

C21H31NO10 (457.1948)

SCHEMBL20875649

C28H27NO5 (457.1889)

Tyr Glu Phe

C23H27N3O7 (457.1849)

Tyr Phe Glu

C23H27N3O7 (457.1849)

Glu Tyr Phe

C23H27N3O7 (457.1849)

Phe Tyr Glu

C23H27N3O7 (457.1849)

Glu Phe Tyr

C23H27N3O7 (457.1849)

Phe Glu Tyr

C23H27N3O7 (457.1849)

phenyl(1,2,9,10-tetramethoxy-6-methyl-5,6-dihydro-4H-dibenzo[de,g]quinolin-7-yl)methanone

C28H27NO5 (457.1889)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.432 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.437

Minocycline

C23H27N3O7 (457.1849)

A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne A tetracycline analogue having a dimethylamino group at position 7 and lacking the methyl and hydroxy groups at position 5. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

4-Epiminocycline

4-Epi Minocycline

C23H27N3O7 (457.1849)

1,2,4-Triazolidine-3,5-dione, 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-4-(2-phenoxyethyl)-

C23H28ClN5O3 (457.1881)

His Asn Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid